Literature DB >> 21233233

Endovascular stroke treatment today.

I Q Grunwald1, A K Wakhloo, S Walter, A J Molyneux, J V Byrne, S Nagel, A L Kühn, M Papadakis, K Fassbender, J S Balami, M Roffi, H Sievert, A Buchan.   

Abstract

The purpose of this study was to review current treatment options in acute ischemic stroke, focusing on the latest advances in the field of mechanical recanalization. These devices recently made available for endovascular intracranial thrombectomy show great potential in acute stroke treatments. Compelling evidence of their recanalization efficacy comes from current mechanical embolectomy trials. In addition to allowing an extension of the therapeutic time window, mechanical recanalization devices can be used without adjuvant thrombolytic therapy, thus diminishing the intracranial bleeding risk. Therefore, these devices are particularly suitable in patients in whom thrombolytic therapy is contraindicated. IV and IA thrombolysis and bridging therapy are viable options in acute stroke treatment. Mechanical recanalization devices can potentially have a clinically relevant impact in the interventional treatment of stroke, but at the present time, a randomized study would be beneficial.

Entities:  

Mesh:

Year:  2011        PMID: 21233233      PMCID: PMC7965694          DOI: 10.3174/ajnr.A2346

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  41 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Combined IV and intra-arterial thrombolysis for acute ischemic stroke.

Authors:  M L Flaherty; D Woo; B Kissela; E Jauch; A Pancioli; J Carrozzella; J Spilker; P Sekar; J Broderick; T Tomsick
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

4.  MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia.

Authors:  Y Pierre Gobin; Sidney Starkman; Gary R Duckwiler; Thomas Grobelny; Chelsea S Kidwell; Reza Jahan; John Pile-Spellman; Alan Segal; Fernando Vinuela; Jeffrey L Saver
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

5.  The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease.

Authors: 
Journal:  Stroke       Date:  2009-07-09       Impact factor: 7.914

6.  Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.

Authors:  Heinrich P Mattle; Marcel Arnold; Dimitrios Georgiadis; Christian Baumann; Krassen Nedeltchev; David Benninger; Luca Remonda; Christian von Büdingen; Anca Diana; Athina Pangalu; Gerhard Schroth; Ralf W Baumgartner
Journal:  Stroke       Date:  2007-12-20       Impact factor: 7.914

7.  Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia.

Authors:  Wade S Smith; Jack W Tsao; Martha E Billings; S Claiborne Johnston; J Claude Hemphill; David C Bonovich; William P Dillon
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

8.  Revascularization results in the Interventional Management of Stroke II trial.

Authors:  T Tomsick; J Broderick; J Carrozella; P Khatri; M Hill; Y Palesch; J Khoury
Journal:  AJNR Am J Neuroradiol       Date:  2008-03       Impact factor: 3.825

9.  Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial.

Authors:  Wade S Smith; Gene Sung; Jeffrey Saver; Ronald Budzik; Gary Duckwiler; David S Liebeskind; Helmi L Lutsep; Marilyn M Rymer; Randall T Higashida; Sidney Starkman; Y Pierre Gobin; Donald Frei; Thomas Grobelny; Frank Hellinger; Dan Huddle; Chelsea Kidwell; Walter Koroshetz; Michael Marks; Gary Nesbit; Isaac E Silverman
Journal:  Stroke       Date:  2008-02-28       Impact factor: 7.914

10.  Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization.

Authors:  Thomas Liebig; Jörg Reinartz; Ralf Hannes; Elina Miloslavski; Hans Henkes
Journal:  Neuroradiology       Date:  2007-10-12       Impact factor: 2.804

View more
  8 in total

1.  Endovascular stroke treatment now and then-procedural and clinical effectiveness and safety of different mechanical thrombectomy techniques over time.

Authors:  Niels von Gadow; Omid Nikoubashman; Jessica Freiherr; Frank Block; Arno Reich; Gunther Fesl; Martin Wiesmann
Journal:  Quant Imaging Med Surg       Date:  2017-02

2.  Safety and efficacy of endovascular sonolysis using the EkoSonic endovascular system in patients with acute stroke.

Authors:  M Kuliha; M Roubec; T Jonszta; J Krajca; D Czerny; A Krajina; K Langová; R Herzig; V Procházka; D Školoudík
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

3.  Interfacility helicopter ambulance transport of neurosurgical patients: observations, utilization, and outcomes from a quaternary level care hospital.

Authors:  Brian P Walcott; Jean-Valery Coumans; Matthew K Mian; Brian V Nahed; Kristopher T Kahle
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

Review 4.  Endovascular therapy for ischemic stroke.

Authors:  Ramana M R Appireddy; Andrew M Demchuk; Mayank Goyal; Bijoy K Menon; Muneer Eesa; Philip Choi; Michael D Hill
Journal:  J Clin Neurol       Date:  2015-01-02       Impact factor: 3.077

5.  Usefulness of computed tomography perfusion in treatment of an acute stroke patient with unknown time of symptom onset.

Authors:  Francis M Fesmire; Bryan S England; Jared S Shell; Thomas G Devlin; Ron C Buchheit
Journal:  West J Emerg Med       Date:  2014-02

6.  Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke.

Authors:  Shaowei Jiang; Aihua Fei; Ya Peng; Jun Zhang; You-Ran Lu; Hai-Rong Wang; Miao Chen; Shuming Pan
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

7.  Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.

Authors:  Feng-Di Liu; Rong Zhao; Xiao-Yan Feng; Yan-Hui Shi; Yi-Lan Wu; Xiao-Lei Shen; Ge-Fei Li; Yi-Sheng Liu; Ying Zhao; Xin-Wei He; Jia-Wen Yin; Mei-Ting Zhuang; Bing-Qiao Zhao; Jian-Ren Liu
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

Review 8.  Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke.

Authors:  Yingchen Li; Qilai Cheng; Guoheng Hu; Tianhao Deng; Qimei Wang; Jianda Zhou; Xinping Su
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.